期刊文献+

儿童非霍奇金淋巴瘤的预后因素 被引量:5

Analysis of Prognosis of Children with Non-Hodgkin′s Lymphoma
暂未订购
导出
摘要 目的探讨影响儿童非霍奇金淋巴瘤(NHL)预后的因素。方法对儿童医学中心1996年1月-2000年12月经病理确诊为NHL患儿30例,根据可能影响预后的因素,包括年龄、性别、免疫分型、全身症状、肿块大小、骨髓浸润、纵隔浸润、肝大或浸润、脾大或浸润及化疗早期反应将患者分组,比较组间生存率的差异。生存统计采用Kaplan-Meier法,组间比较采用Logrank检验。结果巨大肿块组3年生存率明显好于无巨大肿块组(P〈0.01);骨髓无浸润组的3年生存率明显好于有浸润组(P〈0.01);无脾大或浸润组3年无病生存率(DFS)好于有脾大或浸润组(P=0.0255),而3年总生存率二组间比较无显著差异(P=0.0843)。而以其他临床特征分组,组间无显著差异(P〉0.05)。结论有否骨髓浸润和肿块大小对NHL患儿预后有非常显著的影响,而是否有脾大或浸润对NHL患儿DFS有一定影响。 Objective To analyze the factors affecting prognosis of children with non-Hodgkin′s lymphomas(NHL).Methods Thirty patients of childhood NHL histologically proven in Shanghai children′s medical center from Jan.1996 to Dec.2000 were analyzed.The patients were divided into groups according to some clinical factors that may have predictive significance including age,gender,immunologic phenotype,general system symptom,the size of tumor bulk,bone marrow involvement,mediastinal involvement,hepatomegaly or liver involvement,splenomegaly or spleen involvement and early response to chemotherapy,then the difference of survival rate were compared between groups.Survival analysis was performed by the Kaplan-Meier method,and difference between groups were campared using the Log-rank test.Results The 3-year survival rate was better in patients without giant tumor bulk than that with giant tumor bulk(P〈0.01).The 3-year survival rate was also better in the patients without bone marrow involvement than that with bone marrow involvement(P〈0.01).The 3-year disease-free survival rate as better in the patients without splenomegaly or spleen involvement than that with splenomegaly or spleen involvement(P=0.025 5).While there were no significant differences of 3-year overall survival(P=0.084 3).There were no significant differences of the other clinical characteristics (P〉0.05).Conclusions Bone marrow involvement and the size of tumor bulk have very significant influence on prognosis of childhood NHL,and splenomegaly or spleen involvement have significant influence on disease-free survival.It can′t be proven in childhood NHL in this study.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第3期200-201,共2页 Journal of Applied Clinical Pediatrics
关键词 非霍奇金淋巴瘤 儿童 预后 non-Hodgkin′s lymphoma,child,prognosis
  • 相关文献

参考文献13

  • 1栾佐.儿童恶性淋巴瘤的诊断与治疗[J].实用儿科临床杂志,2005,20(1):1-2. 被引量:15
  • 2Armitage JO.Staging non-Hodgkin lymphoma[J].CA Cancer J Clin,2005,55(6):368-376.
  • 3干慧珠,林玉梅,张凤春,张桂珍.非霍奇金淋巴瘤85例临床及预后分析[J].临床血液学杂志,2004,17(3):146-148. 被引量:6
  • 4Burkhardt B,Zimmermann M,Oschlies I,et al.The impact of age and gender on biology,clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence[J].Br J Haematol,2005,131(1):39-49.
  • 5王菁,王丽敏.幽门螺杆菌相关性胃淋巴样组织淋巴瘤85例分析[J].新乡医学院学报,2005,22(4):358-359. 被引量:2
  • 6Sonja G,Genadieva-Stavrik G.Prognostic model for aggressive non-Hodgkin lymphoma[J].Blood (ASH Annual Meeting Abstracts),2005,106:4689.
  • 7Kwak LW,Wilson M,Weiss LM,et al.Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas:the Stanford experiencel[J].J Clin Oncol,1991,9(8):1426-1431.
  • 8Escalon MP,Liu NS,Yang Y,et al.Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma:the M.D.Anderson Cancer Center experience[J].Cancer,2005,103(10):2091-2098.
  • 9张汝鹏,李强,孙涛,王殿昌,郝希山.68例原发性结直肠非霍奇金恶性淋巴瘤临床分析[J].中华胃肠外科杂志,2004,7(1):49-51. 被引量:6
  • 10Gallamini A,Stelitano C,Calvi R,et al.Peripheral T-cell lymphoma unspecified (PTCL-U):A new prognostic model from a retrospective multicentric clinical study[J].Blood,2004,103(7):2474-2479.

二级参考文献20

  • 1邹典斌,郭荣,张秋堂,魏国庆,何飞.流式细胞术在人急性白血病免疫分型中的应用[J].郑州大学学报(医学版),2001,36(1):56-58. 被引量:9
  • 2俞谦,孙为豪,刘顺英,欧希龙,曹大中,俞婷,郭庆明,许曼华,沈云志.原发性胃肠道恶性淋巴瘤临床分析[J].中华消化内镜杂志,2005,22(1):34-36. 被引量:21
  • 3丁训杰 沈迪.实用血液病学[M].上海:上海医科大学出版社,1991.84-95.
  • 4张之南.血液病诊断及疗效标准[M].天津:天津科学技术出版社,1990,31..
  • 5范娣 主编.王德延肿瘤病理诊断学:第 2版[M].天津:天津科学出版社,1999.348-349.
  • 6Wells RI, Arthur DC, Srivastava A, et al. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: children's cancer group study[J]. Leukernia, 2002, 16(4) :601 - 607.
  • 7Kern W, Schoch C, Haferlach T, et al. Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone(S-HAM) salvage therapy: relevance of cytogenetic abnormalities[J]. Leukemia ,2000,14(2) :226 - 231.
  • 8Meusers P. Multicenter randomized therapeutic for advanced centrocgtic lymphoma. Hematol oncol, 1989,7 :365-369.
  • 9Mclaughlin P. StageⅠ-Ⅱ follicular lymphoma treatment results for 76 patients. Cancer, 1986,58: 1596-1602.
  • 10储大同.淋巴瘤的治疗进展[J].中国肿瘤,1995,4:23-23.

共引文献25

同被引文献83

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部